{
  "trial_id": "NCT00419562",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, relationship to proband, fasting plasma glucose, 2-hour plasma glucose, mIAA levels, presence of other autoantibodies, HLA haplotype, history of severe active disease, prior participation in T1DM prevention trials, history of insulin or oral hypoglycemic agent use, history of immunosuppressive drug or glucocorticoid therapy, use of medications influencing glucose, pregnancy status, compliance likelihood.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race/Ethnicity",
        "Region of Enrollment",
        "Stratum"
      ],
      "remaining_candidate_features": [
        "relationship to proband",
        "fasting plasma glucose",
        "2-hour plasma glucose",
        "mIAA levels",
        "presence of other autoantibodies",
        "HLA haplotype",
        "history of severe active disease",
        "prior participation in T1DM prevention trials",
        "history of insulin or oral hypoglycemic agent use",
        "history of immunosuppressive drug or glucocorticoid therapy",
        "use of medications influencing glucose",
        "pregnancy status",
        "compliance likelihood"
      ]
    },
    "processed-gen-response": "Age, sex, relationship to proband, fasting plasma glucose, 2-hour plasma glucose, mIAA levels, presence of other autoantibodies, HLA haplotype, history of severe active disease, prior participation in T1DM prevention trials, history of insulin or oral hypoglycemic agent use, history of immunosuppressive drug or glucocorticoid therapy, use of medications influencing glucose, pregnancy status, compliance likelihood."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Relationship to proband, Fasting plasma glucose, 2-hour plasma glucose, mIAA levels, Presence of other autoantibodies,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Stratum"
      ],
      "remaining_candidate_features": [
        "Relationship to proband",
        "Fasting plasma glucose",
        "2-hour plasma glucose",
        "mIAA levels",
        "Presence of other autoantibodies"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Relationship to proband, Fasting plasma glucose, 2-hour plasma glucose, mIAA levels, Presence of other autoantibodies"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Relationship to Proband, Proband's Age at Diagnosis, Proband's Diabetes Duration, mIAA, Other Autoantibodies, Fasting Plasma Glucose, 2-Hour Plasma Glucose, BMI, Region of Enrollment.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race/Ethnicity",
        "Stratum"
      ],
      "remaining_candidate_features": [
        "Relationship to Proband",
        "Proband's Age at Diagnosis",
        "Proband's Diabetes Duration",
        "mIAA",
        "Other Autoantibodies",
        "Fasting Plasma Glucose",
        "2-Hour Plasma Glucose",
        "BMI"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Relationship to Proband, Proband's Age at Diagnosis, Proband's Diabetes Duration, mIAA, Other Autoantibodies, Fasting Plasma Glucose, 2-Hour Plasma Glucose, BMI, Region of Enrollment."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, proband relationship, body mass index (BMI), fasting plasma glucose, 2-hour plasma glucose, insulin autoantibody (mIAA) levels, other autoantibody levels, HLA DQA1 and DQB1 haplotype, medical history (e.g. severe active disease, immunosuppressive therapy), medication use (e.g. insulin, oral hypoglycemic agents, immunosuppressive drugs).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Stratum",
          "proband relationship"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race/Ethnicity",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "fasting plasma glucose",
        "2-hour plasma glucose",
        "insulin autoantibody (mIAA) levels",
        "other autoantibody levels",
        "HLA DQA1 and DQB1 haplotype",
        "medical history (e.g. severe active disease, immunosuppressive therapy)",
        "medication use (e.g. insulin, oral hypoglycemic agents, immunosuppressive drugs)"
      ]
    },
    "processed-gen-response": "Age, sex, proband relationship, body mass index (BMI), fasting plasma glucose, 2-hour plasma glucose, insulin autoantibody (mIAA) levels, other autoantibody levels, HLA DQA1 and DQB1 haplotype, medical history (e.g. severe active disease, immunosuppressive therapy), medication use (e.g. insulin, oral hypoglycemic agents, immunosuppressive drugs)."
  }
}